Sana Biotechnology (SANA), a clinical-stage biotech company specializing in gene and cell therapies, has recently experienced significant moves in its stock performance, attracting investor attention.

If not, you can flip the stock at any time for a profit. Investors have seriously recognized biotechnology as a distinct market sector since 1993. The Biotechnology Innovation Organization (BIO ...

The improved sales of Nerlynx have been the primary reason for the stock’s increase during the said time. Puma Biotechnology in-licensed global development and commercialization rights for ...